Clinical Trials in Washington

Showing 5401-5420 of 9,462 trials

Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

NCT00551239

RATIONALE: Drugs used in chemotherapy, such as fludarabine and pixantrone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. It is not yet known whether giving fludarabine together with rituximab is more effective with or without pixantrone in treating indolent non-Hodgkin lymphoma. PURPOSE: This randomized phase III trial is studying fludarabine and rituximab to compare how well they work with or without pixantrone in treating patients with relapsed or refractory indolent non-Hodgkin lymphoma.

LeukemiaLymphoma

CTI BioPharmaStarted Aug 2007

Seattle, Washington, United States

COMPLETEDPhase 342 miles

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452

The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.

Childhood Absence EpilepsyPetit Mal EpilepsyEpilepsy+1 more

Children's Hospital Medical Center, Cincinnati453 participantsStarted Jul 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +28 more locations

Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Find Trials by Condition in Washington

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma

Copper IUD Treatment Observation Study

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Doppler Flow Wires in Cerebral Angiography

EVOLVE Short DAPT Study

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

A Study of ARRY-334543 in Patients With Advanced Cancer

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene